🧪CDC Requests Comments on Drug Susceptibility Testing Program
Agency Forms Undergoing Paperwork Reduction Act Review
Summary
The CDC has submitted an information collection request for the Model Performance Evaluation Program related to Mycobacterium tuberculosis drug susceptibility testing. This initiative aims to enhance the quality of testing practices among U.S. laboratories. The program is designed to provide evaluations that help optimize laboratory capabilities in identifying drug-resistant tuberculosis strains, thereby informing continuous program improvement.
Agencies
- Health and Human Services Department
- Centers for Disease Control and Prevention
Business Impact
$$ - Med
The text discusses the CDC’s request for information collection linked to drug susceptibility testing for Mycobacterium tuberculosis, indicating regulatory compliance requirements for involved laboratories. Participation implies a financial, operational, and training burden that businesses must address to maintain service quality and regulatory adherence.